These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 39006326)
21. Panretinal photocoagulation with simultaneous cryoretinopexy or intravitreal bevacizumab for neovascular glaucoma. Tatsumi T; Yamamoto S; Uehara J; Sugawara T; Baba T; Inoue M; Hata H; Mitamura Y Graefes Arch Clin Exp Ophthalmol; 2013 May; 251(5):1355-60. PubMed ID: 23250484 [TBL] [Abstract][Full Text] [Related]
22. Pars plana vitrectomy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma. Kiuchi Y; Nakae K; Saito Y; Ito S; Ito N Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1627-32. PubMed ID: 16639623 [TBL] [Abstract][Full Text] [Related]
23. [Intraocular pressure after cyclophotocoagulation with the diode laser]. Flamm C; Wiegand W Ophthalmologe; 2004 Mar; 101(3):263-7. PubMed ID: 15007607 [TBL] [Abstract][Full Text] [Related]
24. Management of neovascular glaucoma with transscleral cyclophotocoagulation with diode laser alone versus combination transscleral cyclophotocoagulation with diode laser and intravitreal bevacizumab. Fong AW; Lee GA; O'Rourke P; Thomas R Clin Exp Ophthalmol; 2011; 39(4):318-23. PubMed ID: 20973900 [TBL] [Abstract][Full Text] [Related]
25. Cyclodestructive procedures for refractory glaucoma. Chen MF; Kim CH; Coleman AL Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012223. PubMed ID: 30852841 [TBL] [Abstract][Full Text] [Related]
27. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643 [TBL] [Abstract][Full Text] [Related]
28. Supplemental transscleral diode laser cyclophotocoagulation after aqueous shunt placement in refractory glaucoma. Semchyshyn TM; Tsai JC; Joos KM Ophthalmology; 2002 Jun; 109(6):1078-84. PubMed ID: 12045047 [TBL] [Abstract][Full Text] [Related]
29. A comparative study between diode laser cyclophotocoagulation and the Ahmed glaucoma valve implant in neovascular glaucoma: a long-term follow-up. Yildirim N; Yalvac IS; Sahin A; Ozer A; Bozca T J Glaucoma; 2009 Mar; 18(3):192-6. PubMed ID: 19295370 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of 180° Cyclodiode Transscleral Photocoagulation for Refractory Glaucoma. Bezci Aygün F; Mocan MC; Kocabeyoğlu S; İrkeç M Turk J Ophthalmol; 2018 Dec; 48(6):299-303. PubMed ID: 30605936 [TBL] [Abstract][Full Text] [Related]
31. Comparing the efficacy of trabeculectomy and diode laser cyclophotocoagulation in primary open-angle glaucoma. Hasan S; Theilig T; Unterlauft JD Int Ophthalmol; 2019 Nov; 39(11):2485-2496. PubMed ID: 30830546 [TBL] [Abstract][Full Text] [Related]
32. Neovascular glaucoma after vitrectomy in patients with proliferative diabetic retinopathy. Kwon JW; Jee D; La TY Medicine (Baltimore); 2017 Mar; 96(10):e6263. PubMed ID: 28272234 [TBL] [Abstract][Full Text] [Related]
33. Surgical Treatment of Neovascular Glaucoma Secondary to Proliferative Diabetic Retinopathy in Japanese Patients without the Use of Glaucoma Drainage Devices. Takeuchi M; Kanda T; Harimoto K; Sora D; Okazawa R; Sato T J Clin Med; 2024 May; 13(11):. PubMed ID: 38892963 [No Abstract] [Full Text] [Related]
34. Pars plana modified Baerveldt implant versus neodymium:YAG cyclophotocoagulation in the management of neovascular glaucoma. Chalam KV; Gandham S; Gupta S; Tripathi BJ; Tripathi RC Ophthalmic Surg Lasers; 2002; 33(5):383-93. PubMed ID: 12358292 [TBL] [Abstract][Full Text] [Related]
35. Incidence and risk factor analysis of neovascular glaucoma following vitrectomy in patients with proliferative diabetic retinopathy. Hwang S; Kim JH; Choi YH; Thng ZX; Hong EH; Kang MH; Shin YU Sci Rep; 2024 Sep; 14(1):22490. PubMed ID: 39341897 [TBL] [Abstract][Full Text] [Related]
36. Trans-scleral krypton laser cyclophotocoagulation: our experience of its use on patients with neovascular glaucoma. Di Staso S; Genitti G; Verolino M; Sepe M; Scupola A; Balestrazzi E Acta Ophthalmol Scand Suppl; 1997; (224):37-8. PubMed ID: 9589726 [TBL] [Abstract][Full Text] [Related]
37. TRANSSCLERAL DIODE CYCLOPHOTOCOAGULATION IN TREATMENT OF GLAUCOMA. Farraová P; Ondrejková M; Demianová D Cesk Slov Oftalmol; 2020; 76(5):236-242. PubMed ID: 33499646 [TBL] [Abstract][Full Text] [Related]
38. Intravitreal bevacizumab combined with panretinal photocoagulation in the treatment of open angle neovascular glaucoma. Ciftci S; Sakalar YB; Unlu K; Keklikci U; Caca I; Dogan E Eur J Ophthalmol; 2009; 19(6):1028-33. PubMed ID: 19882572 [TBL] [Abstract][Full Text] [Related]
39. Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term. Sun Y; Liang Y; Zhou P; Wu H; Hou X; Ren Z; Li X; Zhao M BMC Ophthalmol; 2016 Aug; 16(1):150. PubMed ID: 27576739 [TBL] [Abstract][Full Text] [Related]
40. Surgical treatment of neovascular glaucoma: a systematic review and meta-analysis. Shchomak Z; Cordeiro Sousa D; Leal I; Abegão Pinto L Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1079-1089. PubMed ID: 30726529 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]